Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.CLL Society and BeOne Medicines Announce Expanded Partnership to Advance Education and Support Across the CLL/SLL Community
BeOne Medicines Q3 Earnings Call Highlights
BeOne Medicines Q3 Earnings Call Highlights
BeOne Medicines (NASDAQ:ONC) Hits New 52-Week High After Better-Than-Expected Earnings
Compared to Estimates, BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: A Look at Key Metrics
BeOne Medicines AG (ONC) Q3 2026 Earnings Call Transcript
BeOne Medicines Announces Third Quarter 2026 Financial Results and Business Updates
U.S. FDA Grants Priority Review to BeOne Medicines' BRUKINSA Combination in First-Line Mantle Cell Lymphoma
Gear Up for BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: Wall Street Estimates for Key Metrics
BeOne Medicines to Present at the Jefferies Global Healthcare Conference
New Strong Buy Stocks for November 3rd
BeOne Medicines (NASDAQ:ONC) Stock: Insider Xiaodong Wang Sells 31,028 Shares
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
BeOne Medicines: Brukinsa And Tevimbra Face A High Bar
BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 5
Oncolytics Biotech (TSE:ONC) Share Price Breaks Above Two Hundred Day Moving Average – Should You Sell?
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
BeOne Medicines (NASDAQ:ONC) Insider Sells $10,890,166.73 in Stock
All You Need to Know About BeOne Medicines Ltd. - Sponsored ADR (ONC) Rating Upgrade to Strong Buy
Already premium?